It was a good week for Merck as the Food and Drug Administration (FDA) has approved the company’s at-home Covid treatment. The agency gave the green light to the company’s antiviral pill to treat Covid-19 for emergency use on Thursday. Merck’s treatment, known as molnupiravir, was developed in partnership with Ridgeback Biotherapeutics. It is now … Continue reading “The FDA Has Cleared the Second At-Home Covid Treatment”
